
    
      Elderly patients diagnosed with pneumonia after getting information and signing informed
      consent will be included in this trial. Simvastatin 20 mg will be administered to
      intervention group, while control group will receive placebo. Both groups will receive drugs
      (or placebo) for 30 days.

      Baseline data will be collected within 24 hours after admission. Then the subject will be
      followed up for 30 days. At the 7th day, patients will be underwent several laboratory tests,
      i.e. serum TNF-α (Tumor Necrosis Factor alpha), IFN-ϒ Interferon gamma), CRP (C-Reactive
      Protein), and PAI-1 (Plasminogen Activator Inhibitor-1). Death from all causes until 30 days
      will be recorded.
    
  